Clinical Trials Logo

Pain, Acute clinical trials

View clinical trials related to Pain, Acute.

Filter by:

NCT ID: NCT04252833 Completed - Surgery Clinical Trials

Open-label, Crossover, Food Effect Study to Evaluate CT-044 in Healthy Human Volunteers

Start date: February 18, 2020
Phase: Phase 1
Study type: Interventional

This open-label study will be conducted to assess the bioavailability and PK of oral single doses of CT-044 following administration with and without food and to evaluate the safety and tolerability of CT-044 when given with and without food.

NCT ID: NCT04245475 Completed - Pain, Acute Clinical Trials

Water-friendly Virtual Reality and Brief Thermal Pain

Start date: January 30, 2020
Phase: N/A
Study type: Interventional

Using immersive virtual reality as a form of pain distraction during a brief "painful but tolerable" temperature.

NCT ID: NCT04244695 Recruiting - Pain, Acute Clinical Trials

Oral Steroid in Controlling Pain After TKA

Start date: September 1, 2019
Phase: Phase 4
Study type: Interventional

To compare efficacy of oral steroid in controlling pain after TKA

NCT ID: NCT04223219 Active, not recruiting - Clinical trials for Coronary Artery Disease

Different Modalities of Analgesia in Open Heart Surgeries in Mansoura University

Start date: December 10, 2019
Phase: Phase 4
Study type: Interventional

Cardiac surgery is associated with post-operative pain which is one of the major problems and remains one of the most controversial issues. Inadequate pain control after cardiac surgery increases the incidence of development of many complications. Intravenous opioids are commonly used for postoperative analgesia either on demand "physician or nurse-controlled" or patient -controlled. Multimodal opioid sparing analgesia has become frequently used, These techniques can be achieved with Dexmedetomidine, low-dose ketamine and magnesium. The study hypotheses that control of perioperative quality of pain with opioid sparing medications may improve analgesia and patient outcome.

NCT ID: NCT04215757 Recruiting - Pain, Acute Clinical Trials

Low Dose Lignocaine Injections as a Treatment Option for Acute Lumbosacral Radiculopathy

Start date: January 20, 2019
Phase: N/A
Study type: Interventional

Low back pain is one of the most common ailments that plagues patients, with nearly 80% of the population developing some form of back pain in their lifetime. Up regulated sodium channels in the nerve root or dorsal root ganglion are the basic cause for the mechano-sensitization and injecting the drug in the peripheral end of the nerve will block these sodium channels, since functionally both ends of the pseudo unipolar neuron are the same.

NCT ID: NCT04196686 Completed - Pain, Acute Clinical Trials

Ice Immersion Using Virtual Reality & Augmented Reality

Start date: July 24, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of different technologies, Virtual Reality and Augmented Reality with modifications as passive content, active content, cognitive load modulation, and positive encouragement coaching to increase the pain threshold as assessed by immersing a hand in ice water.

NCT ID: NCT04178109 Completed - Postoperative Pain Clinical Trials

Oral Use of Dexketoprofen/Tramadol for Acute Postoperative Pain in Total Hip Replacement With a Direct Anterior Approach.

Start date: January 10, 2019
Phase: Phase 2
Study type: Interventional

Pain is a global public health issue and represents the most common reason for both physician consultation and hospital admissions . When unrelieved or poorly controlled, it is associated with medical complications, poor patient satisfaction and increased risk of developing chronic pain. Dexketoprofen is a new NSAID treating acute postoperative pain and when it combined with tramadol may have a better effect. The purpose of this study is to evaluate the analgesic effect of the oral use of the combination of dexketoprofen/tramadole on the reduction of postoperative pain after total hip arthroplasty with minimal invasive anterior approach (AMIS).

NCT ID: NCT04177862 Completed - Pain Clinical Trials

Sublingual Sufentanil vs Intravenous Fentanyl for Acute Pain in the Ambulatory Surgery Center

Start date: December 11, 2019
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine if a single dose of sublingual sufentanil is as or more efficacious than a single dose of IV fentanyl in a post anesthesia care setting.

NCT ID: NCT04177537 Completed - Back Pain Clinical Trials

Real-World Experience of Athletes Treated With SAM

Start date: October 1, 2015
Phase:
Study type: Observational

Low-intensity continuous ultrasound (LICUS) is an FDA-approved bio regenerative technology, applied with a wearable device (SAM, Zetroz Systems LLC) for daily use. The treatment provides long-duration ultrasound for approximately four hours. This report included a retrospective convenience sample of 6 athletes from one sports medicine and rehabilitation facility. The objective of this report is to examine the real-world outcome data on symptoms improvement and return to function using Sam. It was hypothesized that LICUS stimulation, in conjunction with traditional therapies, will accelerate the healing process of musculoskeletal tissue leading to a reduction in pain, increase functionality, and a higher probability of returning to work and sports-related activities. The sample included athletes with sports-related musculoskeletal injuries. Demographics, injury history, treatment history, and clinical outcomes data were retrospectively collected for athletes who were treated with SAM in conjunction with traditional therapies. Clinical results showed a benefit from the treatment with a decrease in pain (100%), and 3 out of 6 athletes were able to return to work or sports (50%). Overall the study shows that Sam accelerates the healing of soft tissue leading to a decrease in both acute and chronic pain.

NCT ID: NCT04175743 Active, not recruiting - Surgery Clinical Trials

Double-blind, Placebo-control, Study to Evaluate the Safety and Pharmacokinetics of CT-044 HCl, in Healthy Volunteers

Start date: December 4, 2019
Phase: Phase 1
Study type: Interventional

This study will be conducted to assess safety, tolerability, and PK of CT-044 HCl in normal healthy volunteers, in a traditional sequential multiple ascending dose paradigm. The multiple-dose escalation is designed to mimic the manner in which the product (CT-044 HCl) would be used to manage ongoing pain in patients (i.e., multiple dosing).